Purchase Order W81K0219P0018
Award Date 11/1/18
Potential Completion Date 10/31/21
Potential Value $27K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
LEWIS MCCHORD, WA 98431, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for medical and surgical instruments, equipment, and supplies to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $4,710.08 firm fixed price Blanket Purchase Agreement (BPA) call was awarded by the Department of Defense's Defense Health Agency. The contract is not designated as a set-aside. Roche Diagnostics holds multiple...
- This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics and laboratory equipment. The $106,183.68 contract is for providing blood analysis equipment and associated testing services without any set-aside designation. Roche has received numerous awards from federal agencies, including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services,...
- This federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and medical equipment, was issued by a Civilian agency, the Office of the Director. The $6,487 firm fixed-price Blanket Purchase Agreement (BPA) Call is for drugs and biologicals, with no set-aside designation. Roche Diagnostics holds multiple significant Indefinite Delivery Contracts (IDCs) and BPAs across federal agencies, including a $37 million BPA with...
- This federal contract award was made by the Office of the Director, a civilian federal agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $6,575.60 firm fixed price contract is a Blanket Purchase Agreement (BPA) call for DRUGS AND BIOLOGICALS, with a performance period ending on December 31, 2012. The contract does not have a set-aside designation,...
- This federal contract award is for molecular testing equipment, with a ceiling value of $247,811.23. The contract was awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, on July 11, 2025. The contract is a Blanket Purchase Agreement (BPA) Call with a firm fixed price pricing type. The funding agency is the Defense Health Agency, a defense agency. The contract does not have a set-aside designation,...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, which is a Blanket Purchase Agreement (BPA) call with a Firm Fixed Price (FFP) pricing type, has a ceiling value of $6,525.40 and was awarded on August 2, 2013 by the Office of the Chief Operating Officer, a civilian federal agency. The contract does not have a set-aside...
- This federal contract award was made by the Office of the Director, a civilian federal agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $14,454.30 firm fixed price contract is a Blanket Purchase Agreement (BPA) call for DRUGS AND BIOLOGICALS, with a performance period ending on December 31, 2012. The contract does not have a set-aside designation,...
- This federal contract award is for a chemistry analyzer from Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $9,280.72 firm fixed-price purchase order was awarded on October 1, 2021 by the Defense Health Agency, with an ultimate completion date of September 30, 2026. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostic products, laboratory instruments, and associated...
- The Department of the Army Medical Command awarded a $177,482.40 firm fixed price delivery order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the provision of test reagents and has a completion date of September 30, 2022. Roche has previously received other federal contract awards, including Indefinite Delivery Contracts and Blanket Purchase Agreements, to supply a range of medical...
- This federal contract award to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics and laboratory equipment, is for the delivery of ROCHE COBAS products to the Department of the Army Medical Command. The $200,495.00 firm fixed-price purchase order does not have a set-aside designation. Roche Diagnostics has provided similar medical equipment, reagents, and testing services to various federal agencies, including the Department of Veterans Affairs, Department of Defense, and...